With the S&P 500 about to end its best month in almost 40 years, many would be happy to cash in gains and start packing for the ski slopes.
With the S&P 500 about to end its best month in almost 40 years, many would be happy to cash in gains and start packing for the ski slopes.
Little spheres deliver medicine slowly and keep it inside the knee.
Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday.
Stock futures pointed to a higher open for equities on Wall Street on Monday, building on sharp gains in the previous session, with futures for the S&P 500, Dow Jones and Nasdaq 100 up 0.4 to 0.5 percent.
The conglomerate will divide itself into a medical products firm (which will retain the “Abbott” name) and an as-yet-unnamed pharmaceutical research & development entity.
Biocon Ltd, India top biotechnology company, reported a 4 percent drop in quarterly profit due to higher energy costs and rise in wages, but said strong demand from branded formulations offered opportunities for growth.
The Chicago-based company will keep its diversified medical products division under the Abbott name and spin off its research-based pharmaceuticals unit.
Roche Holding AG expects the strong Swiss franc to shave 14 percent off its full-year earnings, the Swiss drugmaker said on Thursday after the red-hot currency took a hefty chunk out of its third-quarter sales.
Cytisine, a plant-based drug discovered by the Soviet Union more than 40 years ago, may be the key to lowering cigarette smoking rates in the developing world.
Combination of Afinitor® and Aromasin can buy you more time before the breast cancer situation worsens.
Scientists have found a way to prevent HIV from damaging the immune system and say their discovery may offer a new approach to developing a vaccine against AIDS.
Despite the FDA advisory panel's backing, RBC Capital Markets does not believe Johnson & Johnson's (NYSE: JNJ) Xarelto is well positioned to receive marketing approval on Nov. 5.
Stock index futures pointed to a lower open on Thursday as data showed a weaker labor market ahead of a speech by U.S. President Barack Obama detailing his plan for jobs growth.
AstraZeneca Plc's key cholesterol drug Crestor failed to beat Pfizer Inc's Lipitor in a head-to-head clinical study, limiting any protection the British company will get as its U.S. rival faces competition from cheap generic copies.
IBM, the No. 2 computer services company, has snapped up technology players in Canada and the UK -- demonstrating an appetite for new technologies but also for tax advantages.
Pfizer Inc
reached a settlement with Dr. Reddy's Laboratories , an Indian drugmaker that has been fighting in court to launch cheaper generic forms of Pfizer's blockbuster cholesterol fighter, the companies said on Wednesday .Roche expects a new generation of drugs targeted at specific groups of patients to make up half its portfolio in 10 years, a shift that is pushing the boundaries of modern medicine.
New York City-based Pfizer Inc. gained FDA approval for their drug Xalkori, the first new medicine in several years for deadly, advanced lung cancer, according to new research.
Thousands of Washington lobbyists are scrambling to influence the work of a congressional super committee given the job of identifying up to $1.5 trillion in deficit reductions, with many worried about how to gain access to its 12 members.
An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market.
The Food and Drug Administration (FDA) has given the approval for a new Pfizer drug which will be useful for treating certain group of lung cancer patients having specific genetic mutation.
